The effectiveness of Boston Scientific pain management solutions have been proven in a number of important clinical trials. Below you can find information about upcoming clinical trials focused on pain management.
The ENLITEN Study
No one understands chronic pain better than those who live with it every day. Boston Scientific is conducting the ENLITEN Study to help raise our understanding of what chronic pain is REALLY like for people like you.
In the ENLITEN Study you will use a mobile app to answer questions about your pain, how it impacts your daily life, and how the different types of therapy you’re using to treat it are working.
To participate in the study, you must be:
- 22 years of age or older
- Planning to receive or already using a commercially approved, interventional medical device therapy/procedure (e.g., a Spinal Cord Stimulator (SCS) system, or the Vertiflex™ Procedure†) to treat your chronic pain
- A current resident of the United States or District of Columbia
- Comfortable reading, writing, and speaking English
You must also have a smartphone compatible with the study app and a valid email address.
If you would like to participate in the ENLITEN study, start by downloading the myStudyPartner+ Clinical Study App from your device’s app store. You can also scan this QR code with your smartphone camera to get the app.
Once you open the app, you will be asked to Allow Paste from Messages. Either Allow Paste or simply enter the ENLITEN study code, which is 124020266. You will then be prompted to answer a few questions to see if you are a candidate to participate in the study. If you are, you will receive an email with a consent form and instructions on how to begin your participation in the study.
The FAST™ Study
Chronic pain affects 1 in 5 adults, and can impact nearly every aspect of daily life - from work performance, to family life, to social interactions.1 For many people, this pain affects the lower back and/or legs, and can be caused by a variety of underlying conditions.
If you’ve struggled with chronic low back and/or leg pain for at least 6 months that has not responded to other treatments, you may be a candidate for the FAST Study. The study uses the WaveWriter™ Spinal Cord Stimulator System - an FDA-approved, drug-free therapy shown to effectively relieve chronic pain and improve quality of life.2,3
The SCOPE Study
If you’ve been living with dull or aching leg pain, numbness or cramping (with or without back pain), you may have lumbar spinal stenosis (LSS) - and you have options. One option is the Vertiflex™ Procedure†, a minimally-invasive medical solution that can help treat the root cause of LSS. The Vertiflex Procedure offers a safe and effective alternative to more invasive surgical options, with most people returning home the same day they receive the Vertiflex Procedure.
The Vertiflex Procedure is currently being offered at select US centers through a new clinical research study called the SCOPE Study. If you qualify and choose to join the SCOPE Study you will be treated by a local physician specialist, and will be compensated for your time and travel for attending follow-up visits to evaluate your progress.
†Superion™ Indirect Decompression System.
References: 1. Dahlhamer J, Lucas J, Zelaya, C, et al. Prevalence of Chronic Pain and High-Impact Chronic Pain Among Adults — United States, 2016. MMWR Morb Mortal Wkly Rep 2018;67:1001–1006. 2. Veizi E, Hayek SM, North J, et al. Spinal cord stimulation (SCS) with anatomically guided (3D) neural targeting shows superior chronic axial low back pain relief compared to traditional SCS—LUMINA Study. Pain Med. 2017;18(8):1534-1548. 3. Thomson SJ, Kruglov D, Duarte RV. A spinal cord stimulation service review from a single centre using a single manufacturer over a 7.5 year follow-up period. Neuromodulation. 2017;20(6):589-599. N=321